Log In
Search
While a movement to legalise psychedelics in the US has gained ground, the UK has lagged behind in progressive drug policy. But could a game changing new approach to mental illness treatment swap xanax for ketamine? Join world-famous neuropsychopharmacologist Prof. David Nutt of the Centre for Psychedelic Research at Imperial College London for an evening of conversation about the cutting edge frontiers of psychedelic therapy.
Join the discussion
Join like minded readers that support our journalism by becoming a paid subscriber
To join the discussion in the comments, become a paid subscriber.
Join like minded readers that support our journalism, read unlimited articles and enjoy other subscriber-only benefits.
Subscribe